Cancer Screening: A Proposal for Renal Cancer Screening with Computed Tomography - Abstract
It has been estimated that every year in Europe and in the USA about 26,000 and 13,000 people die of renal cell carcinoma, respectively. For localized disease 5-year relative survival rate is 92.8% whereas for regional and metastatic disease is 64, 2% and 11.9% respectively. Thus, there are conditions to elaborate a screening
program for renal cancer, in particular for a subset of population which is at high risk (eg smokers, obese), in which the prevalence of the disease is higher.
The most accurate imaging test for the diagnosis of renal masses is CT, in particular for the small renal masses, in which there are more therapeutic options and for whom there a higher survival rate.